Cooperative Agreement 2322305
Award Date
10/1/23
Completion Date
9/30/25
Dollars Obligated
$1M
Federal Agency
National Science Foundation
Awardee
123 See, Inc. (E79BCBZLX3L6)
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Boston, MA 02109, USA
Similar Awards
The National Science Foundation awarded 123 See, Inc. a $276,000 Small Business Innovation Research Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant supports the development of a vision care station for on-demand rapid examination of visual performance. The station will allow for quick evaluation of vision without an extensive appointment. The 15-month project period runs from December 2021 through February 2023. The NSF Technology,...
Oculomotor Technologies Inc. was awarded a $1,000,000 cooperative agreement from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel system for diagnosis of vision disorders. The two-year award, issued on May 1, 2021 with a completion date of April 30, 2023, will support Oculomotor Technologies' efforts to advance science and engineering research leading to breakthrough technologies for solutions to national...
This $275,000 Project Grant award, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a novel adaptive perimetry software tool for early detection of vision loss due to glaucoma. The project, conducted by Envision Health Technologies Inc., a woman-owned small business, seeks to improve upon current standard-of-care static automated perimetry (SAP) testing by creating a more sensitive and precise adaptive testing...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $881,796 to Siloam Vision, Inc. to develop two advanced, laser-based, AI-enabled retinal imaging systems. The key innovations include: A wider field-of-view camera design that can be paired with either a scanning laser ophthalmoscope (SLO) or optical coherence tomography (OCT) system, offering 2D or 3D imaging of the entire retina without requiring pupil dilation. Super-resolution AI algorithms to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 to Diffract Technology Inc. is focused on developing a novel, high-resolution 3D optical metrology tool for precision manufacturing and industrial applications. The project aims to create a computer-generated holographic system capable of performing rapid, non-contact 3D measurements with sub-10-micron resolution over a large field of view. The advanced 3D...
Visionaire Products, Inc. received a $256,000 Project Grant award from the National Science Foundation on February 15, 2021 to complete work by July 31, 2021. The grant was awarded under the NSF's Engineering program (CFDA 47.041) to support development of a novel, microfluidic device to improve collection and analysis of biopsy samples from ocular paracentesis procedures. Specifically, the funding enables Visionaire Products to advance a microfluidic technology designed to more efficiently...
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I Project Grant award, funded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, is to develop a subtractive-waveguide-based display technology for augmented reality (AR) smart glasses. The $275,000 grant, awarded on March 1, 2024, aims to create a display solution that can achieve pixel-wise transparency control and hard-edge occlusion using a single CMOS display panel. This would...
This $600,000 Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop an integrated platform to better understand and address glaucoma-induced neurodegeneration. The key products and services to be delivered include: An injectable microbead-based in vivo flow occlusion model to replicate glaucoma-like conditions and achieve sustained intraocular pressure (IOP) elevation. A non-invasive electroretinogram (ERG) recording system to monitor...